Recruiting
Hormone receptor positive breast cancer
RecruitingStudy on the Effects of Ketorolac and Pregabalin in Patients Undergoing Surgery for Early Estrogen Receptor-Positive Breast Cancer
Registered drugNo placebo
Study on the Effects of Ketorolac and Pregabalin in Patients Undergoing Surgery for Early Estrogen Receptor-Positive Breast Cancer
Registered drugNo placebo
- Disease:Hormone receptor positive breast cancer
- Substances:KetorolacPregabalin
Countries:
Belgium
Belgium- Participants:18–64 years · 65+ years
- Substances:Ketorolac
